Suppr超能文献

G蛋白偶联受体激酶5在散发性帕金森病发病机制中的作用

The role of G-protein-coupled receptor kinase 5 in pathogenesis of sporadic Parkinson's disease.

作者信息

Arawaka Shigeki, Wada Manabu, Goto Saori, Karube Hiroki, Sakamoto Masahiro, Ren Chang-Hong, Koyama Shingo, Nagasawa Hikaru, Kimura Hideki, Kawanami Toru, Kurita Keiji, Tajima Katsushi, Daimon Makoto, Baba Masanori, Kido Takashi, Saino Sachiko, Goto Kaoru, Asao Hironobu, Kitanaka Chihumi, Takashita Emi, Hongo Seiji, Nakamura Takao, Kayama Takamasa, Suzuki Yoshihiro, Kobayashi Kazuo, Katagiri Tadashi, Kurokawa Katsuro, Kurimura Masayuki, Toyoshima Itaru, Niizato Kazuhiro, Tsuchiya Kuniaki, Iwatsubo Takeshi, Muramatsu Masaaki, Matsumine Hiroto, Kato Takeo

机构信息

Department of Neurology, Hematology, Metabolism, Endocrinology and Diabetology, Faculty of Medicine, Yamagata University, Yamagata 990-9585, Japan.

出版信息

J Neurosci. 2006 Sep 6;26(36):9227-38. doi: 10.1523/JNEUROSCI.0341-06.2006.

Abstract

Sporadic Parkinson's disease (sPD) is a common neurodegenerative disorder, characterized by selective degeneration of dopaminergic neurons in the substantia nigra. Although the pathogenesis of the disease remains undetermined, phosphorylation of alpha-synuclein and its oligomer formation seem to play a key role. However, the protein kinase(s) involved in the phosphorylation in the pathogenesis of sPD has not been identified. Here, we found that G-protein-coupled receptor kinase 5 (GRK5) accumulated in Lewy bodies and colocalized with alpha-synuclein in the pathological structures of the brains of sPD patients. In cotransfected cells, GRK5 phosphorylated Ser-129 of alpha-synuclein at the plasma membrane and induced translocation of phosphorylated alpha-synuclein to the perikaryal area. GRK5-catalyzed phosphorylation also promoted the formation of soluble oligomers and aggregates of alpha-synuclein. Genetic association study revealed haplotypic association of the GRK5 gene with susceptibility to sPD. The haplotype contained two functional single-nucleotide polymorphisms, m22.1 and m24, in introns of the GRK5 gene, which bound to YY1 (Yin Yang-1) and CREB-1 (cAMP response element-binding protein 1), respectively, and increased transcriptional activity of the reporter gene. The results suggest that phosphorylation of alpha-synuclein by GRK5 plays a crucial role in the pathogenesis of sPD.

摘要

散发性帕金森病(sPD)是一种常见的神经退行性疾病,其特征是黑质中多巴胺能神经元的选择性退化。尽管该疾病的发病机制尚未确定,但α-突触核蛋白的磷酸化及其寡聚体形成似乎起着关键作用。然而,参与sPD发病机制中磷酸化过程的蛋白激酶尚未被鉴定出来。在此,我们发现G蛋白偶联受体激酶5(GRK5)在路易小体中积累,并在sPD患者大脑的病理结构中与α-突触核蛋白共定位。在共转染细胞中,GRK5在质膜上使α-突触核蛋白的Ser-129位点磷酸化,并诱导磷酸化的α-突触核蛋白向核周区域转运。GRK5催化的磷酸化还促进了α-突触核蛋白可溶性寡聚体和聚集体的形成。遗传关联研究揭示了GRK5基因单倍型与sPD易感性的关联。该单倍型在GRK5基因内含子中包含两个功能性单核苷酸多态性,即m22.1和m24,它们分别与YY1(阴阳-1)和CREB-1(环磷酸腺苷反应元件结合蛋白1)结合,并增加了报告基因的转录活性。结果表明,GRK5介导的α-突触核蛋白磷酸化在sPD的发病机制中起关键作用。

相似文献

1
The role of G-protein-coupled receptor kinase 5 in pathogenesis of sporadic Parkinson's disease.
J Neurosci. 2006 Sep 6;26(36):9227-38. doi: 10.1523/JNEUROSCI.0341-06.2006.
2
Identification of G-protein coupled receptor kinase 2 in paired helical filaments and neurofibrillary tangles.
J Neuropathol Exp Neurol. 2006 Dec;65(12):1157-69. doi: 10.1097/01.jnen.0000248542.82681.12.
4
In vivo modulation of polo-like kinases supports a key role for PLK2 in Ser129 α-synuclein phosphorylation in mouse brain.
Neuroscience. 2014 Jan 3;256:72-82. doi: 10.1016/j.neuroscience.2013.09.061. Epub 2013 Oct 12.
5
Unbiased Proteomics of Early Lewy Body Formation Model Implicates Active Microtubule Affinity-Regulating Kinases (MARKs) in Synucleinopathies.
J Neurosci. 2017 Jun 14;37(24):5870-5884. doi: 10.1523/JNEUROSCI.2705-16.2017. Epub 2017 May 18.
6
Lack of association between G-protein coupled receptor kinase 5 gene and Parkinson's disease.
Am J Med Genet B Neuropsychiatr Genet. 2011 Jan;156B(1):104-7. doi: 10.1002/ajmg.b.31129. Epub 2010 Nov 2.
7
Contribution of endogenous G-protein-coupled receptor kinases to Ser129 phosphorylation of alpha-synuclein in HEK293 cells.
Biochem Biophys Res Commun. 2009 Jul 3;384(3):378-82. doi: 10.1016/j.bbrc.2009.04.130. Epub 2009 May 3.
8
α-Synuclein phosphorylation as a therapeutic target in Parkinson's disease.
Rev Neurosci. 2012 Mar 21;23(2):191-8. doi: 10.1515/revneuro-2011-0067.
9
Interplay between sumoylation and phosphorylation for protection against α-synuclein inclusions.
J Biol Chem. 2014 Nov 7;289(45):31224-40. doi: 10.1074/jbc.M114.559237. Epub 2014 Sep 17.
10
Localization of CKII beta subunits in Lewy bodies of Parkinson's disease.
J Neurol Sci. 2008 Mar 15;266(1-2):9-12. doi: 10.1016/j.jns.2007.08.027. Epub 2007 Sep 19.

引用本文的文献

1
Protein kinases in neurodegenerative diseases: current understandings and implications for drug discovery.
Signal Transduct Target Ther. 2025 May 7;10(1):146. doi: 10.1038/s41392-025-02179-x.
2
Microcystin-LR Exposure Damages Neurons by Inducing α-Syn Aggregation via MAPK4/GATA2/SNCA and PP2A/GRKs Pathways.
Mol Neurobiol. 2025 May;62(5):6195-6211. doi: 10.1007/s12035-024-04683-7. Epub 2024 Dec 30.
3
Co-expression-wide association studies link genetically regulated interactions with complex traits.
medRxiv. 2024 Dec 13:2024.10.02.24314813. doi: 10.1101/2024.10.02.24314813.
4
α-Synuclein pathology as a target in neurodegenerative diseases.
Nat Rev Neurol. 2025 Jan;21(1):32-47. doi: 10.1038/s41582-024-01043-w. Epub 2024 Nov 28.
5
Uncovering conserved networks and global conformational changes in G protein-coupled receptor kinases.
Comput Struct Biotechnol J. 2024 Sep 28;23:3445-3453. doi: 10.1016/j.csbj.2024.09.014. eCollection 2024 Dec.
8
Alpha synuclein post translational modifications: potential targets for Parkinson's disease therapy?
Front Mol Neurosci. 2023 May 25;16:1197853. doi: 10.3389/fnmol.2023.1197853. eCollection 2023.
9
G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders.
Signal Transduct Target Ther. 2023 May 3;8(1):177. doi: 10.1038/s41392-023-01427-2.
10
DOPAnization of tyrosine in α-synuclein by tyrosine hydroxylase leads to the formation of oligomers.
Nat Commun. 2022 Nov 12;13(1):6880. doi: 10.1038/s41467-022-34555-4.

本文引用的文献

1
Molecular pathophysiology of Parkinson's disease.
Annu Rev Neurosci. 2005;28:57-87. doi: 10.1146/annurev.neuro.28.061604.135718.
2
Alpha-synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells.
J Neurosci. 2005 Jun 8;25(23):5544-52. doi: 10.1523/JNEUROSCI.0482-05.2005.
4
Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.
Neuron. 2004 Nov 18;44(4):601-7. doi: 10.1016/j.neuron.2004.11.005.
5
Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease.
Neuron. 2004 Nov 18;44(4):595-600. doi: 10.1016/j.neuron.2004.10.023.
6
Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases.
Nat Cell Biol. 2004 Nov;6(11):1054-61. doi: 10.1038/ncb1104-1054.
7
Genetic clues to the pathogenesis of Parkinson's disease.
Nat Med. 2004 Jul;10 Suppl:S58-62. doi: 10.1038/nm1068.
8
Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration.
Protein Pept Lett. 2004 Jun;11(3):213-28. doi: 10.2174/0929866043407174.
9
Alpha-synuclein and Parkinson's disease.
FASEB J. 2004 Apr;18(6):617-26. doi: 10.1096/fj.03-0338rev.
10
A predicted amphipathic helix mediates plasma membrane localization of GRK5.
J Biol Chem. 2004 Apr 23;279(17):17989-95. doi: 10.1074/jbc.M310738200. Epub 2004 Feb 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验